Figure 5.
![Figure 5. TZD-induced changes in single-channel lifetime and appearance frequency. Relative changes in gA−(13) (red squares) and AgA(15) (blue circles) channel lifetimes as a function of [TZD], normalized to the lifetimes before TZD addition for: (A) troglitazone (TRO), (B) rosiglitazone (ROS), (C) pioglitazone (PIO), and (D) ciglitazone (CIG; n = 4–7). The appearance frequency after is normalized to the appearance frequency before the addition of the TZD: (E) 1 µM troglitazone (TRO), (F) 30 µM rosiglitazone (ROS), (G) pioglitazone (PIO), and (H) ciglitazone (CIG; n = 2–4).](https://cdn.rupress.org/rup/content_public/journal/jgp/138/2/10.1085_jgp.201010529/5/jgp_201010529r_rgb_fig5.jpeg?Expires=1768966332&Signature=kquYeu31Z0KEVeaMRxcy2qhmouqN6hLFArb8RUYkNbhuua1A1iGdQ1AWdUnb1rHbXgb4TR-uExAtTl2eZlvMO1cRZ4WYPM2nUYVYREimq4sijbTwXPWnegz4vBrOOzASruL0dsax-91uent72CDWOufEwNxI1YnqAI7pJR3eAr6VB0eOXDrLqyBIF7fpNbiGIn55yf-F0rTGQmyq-1fO9Z-zvd-XvQUKY2oLrkAYbx2Lp4GQA4jaGkMXqNouSLdFKN5EK1MjY-dryS-ZJ7q8zJp27KIB3SjfVMz9FfrQSe71TWko8MWrejl7XJagLHK2EfOV9iSpFmgtL-N4WQfITA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
TZD-induced changes in single-channel lifetime and appearance frequency. Relative changes in gA−(13) (red squares) and AgA(15) (blue circles) channel lifetimes as a function of [TZD], normalized to the lifetimes before TZD addition for: (A) troglitazone (TRO), (B) rosiglitazone (ROS), (C) pioglitazone (PIO), and (D) ciglitazone (CIG; n = 4–7). The appearance frequency after is normalized to the appearance frequency before the addition of the TZD: (E) 1 µM troglitazone (TRO), (F) 30 µM rosiglitazone (ROS), (G) pioglitazone (PIO), and (H) ciglitazone (CIG; n = 2–4).
